Jefferies Group’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $810K | Buy |
+7,750
| New | +$850K | 0.01% | 867 |
|
|
2022
Q1 | – | Sell |
-30,408
| Closed | -$3.75M | – | 2003 |
|
|
2021
Q4 | $3.75M | Sell |
30,408
-23,570
| -44% | -$3.08M | 0.02% | 570 |
|
|
2021
Q3 | $7.67M | Buy |
53,978
+52,521
| +3,605% | +$7.73M | 0.06% | 326 |
|
|
2021
Q2 | $228K | Sell |
1,457
-5,337
| -79% | -$865K | ﹤0.01% | 1379 |
|
|
2021
Q1 | $1.06M | Buy |
+6,794
| New | +$1.05M | 0.01% | 884 |
|
|
2020
Q4 | – | Sell |
-488
| Closed | -$65K | – | 1840 |
|
|
2020
Q3 | $65K | Sell |
488
-21,923
| -98% | -$2.86M | ﹤0.01% | 1269 |
|
|
2020
Q2 | $2.6K | Buy |
22,411
+21,381
| +2,076% | +$2.46M | 0.03% | 466 |
|
|
2020
Q1 | $101K | Sell |
1,030
-4,002
| -80% | -$525K | ﹤0.01% | 1788 |
|
|
2019
Q4 | $731K | Sell |
5,032
-22,321
| -82% | -$3.08M | 0.01% | 1623 |
|
|
2019
Q3 | $3.65M | Sell |
27,353
-53,906
| -66% | -$6.96M | 0.03% | 694 |
|
|
2019
Q2 | $9.29M | Buy |
81,259
+56,135
| +223% | +$6.57M | 0.07% | 248 |
|
|
2019
Q1 | $3.12M | Buy |
25,124
+11,176
| +80% | +$1.27M | 0.03% | 665 |
|
|
2018
Q4 | $1.41M | Sell |
13,948
-80,471
| -85% | -$9.05M | 0.01% | 994 |
|
|
2018
Q3 | $12.1M | Sell |
94,419
-4,284
| -4% | -$509K | 0.08% | 217 |
|
|
2018
Q2 | $10.7M | Buy |
98,703
+56,152
| +132% | +$6.11M | 0.06% | 245 |
|
|
2018
Q1 | $4.5M | Sell |
42,551
-25,373
| -37% | -$2.95M | 0.02% | 514 |
|
|
2017
Q4 | $7.96M | Buy |
67,924
+65,200
| +2,394% | +$7.37M | 0.04% | 390 |
|
|
2017
Q3 | $310K | Buy |
+2,724
| New | +$314K | ﹤0.01% | 1866 |
|
|
2017
Q2 | – | Sell |
-22,954
| Closed | -$2.72M | – | 2629 |
|
|
2017
Q1 | $2.72M | Buy |
22,954
+10,641
| +86% | +$1.21M | 0.02% | 767 |
|
|
2016
Q4 | $1.23M | Sell |
12,313
-2,735
| -18% | -$293K | 0.01% | 1157 |
|
|
2016
Q3 | $1.9M | Sell |
15,048
-9,035
| -38% | -$1.12M | 0.01% | 963 |
|
|
2016
Q2 | $2.81M | Buy |
24,083
+10,132
| +73% | +$1.15M | 0.01% | 720 |
|
|
2016
Q1 | $1.44M | Buy |
13,951
+13,848
| +13,445% | +$1.34M | 0.01% | 990 |
|
|
2015
Q4 | $10K | Sell |
103
-23,253
| -100% | -$2.28M | ﹤0.01% | 2203 |
|
|
2015
Q3 | $2.13M | Buy |
23,356
+14,379
| +160% | +$1.44M | 0.01% | 867 |
|
|
2015
Q2 | $952K | Sell |
8,977
-4,078
| -31% | -$451K | ﹤0.01% | 1263 |
|
|
2015
Q1 | $1.49M | Buy |
+13,055
| New | +$1.49M | 0.01% | 878 |
|
|
2014
Q4 | – | Sell |
-14,907
| Closed | -$1.57M | – | 2393 |
|
|
2014
Q3 | $1.46M | Sell |
14,907
-2,462
| -14% | -$242K | 0.01% | 847 |
|
|
2014
Q2 | $1.75M | Buy |
17,369
+13,866
| +396% | +$1.35M | 0.01% | 688 |
|
|
2014
Q1 | $322K | Buy |
3,503
+603
| +21% | +$55.6K | ﹤0.01% | 1496 |
|
|
2013
Q4 | $262K | Buy |
+2,900
| New | +$251K | ﹤0.01% | 1449 |
|
|
2013
Q3 | – | Sell |
-30,280
| Closed | -$2.2M | – | 2234 |
|
|
2013
Q2 | $2.2M | Buy |
+30,280
| New | +$2.26M | 0.02% | 474 |
|
Other funds holding ZBH
Jefferies Group's ZBH Position: Q3 2022 in Review
Jefferies Group opened a new position in Zimmer Biomet (ZBH) in Q3 2022: 7,750 shares worth $810K. The stake represents 0.01% of the portfolio and ranks #867 among its holdings. This is a return to the name: Jefferies Group previously reported a position in ZBH as recently as Q4 2021.
Jefferies Group first reported a position in ZBH in Q2 2013 and has held it in 32 quarters since. The position peaked at $12.1M in Q3 2018. 919 funds tracked by Wall St. Rank hold ZBH as of Q3 2022.
- Jefferies Group held 7,750 shares of Zimmer Biomet worth $810K as of Q3 2022.
- Zimmer Biomet was a new Jefferies Group position in Q3 2022.
- Zimmer Biomet made up 0.01% of Jefferies Group's portfolio in Q3 2022, its #867 holding.
- Jefferies Group first reported a position in Zimmer Biomet in Q2 2013 and has held it in 32 quarters since.
- Jefferies Group's Zimmer Biomet position peaked at $12.1M in Q3 2018.
- 919 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2022.
Based on Jefferies Group's 13F filing for Q3 2022, filed 14 Nov 2022.